Celldex Therapeutics buy Wells Fargo & Company
Start price
13.05.26
/
50%
€27.84
Target price
13.05.27
€46.01
Performance (%)
-10.74%
Price
03.06.26
€24.50
Summary
This prediction is currently active. The price of Celldex Therapeutics has decreased since the start of the prediction. Compared to the start price this results in a performance of -10.74%. This prediction currently runs until 13.05.27. The prediction end date can be changed by Wells_Fargo___Compan at any time. Wells_Fargo___Compan has 50% into this predictionPerformance without dividends (%)
| Name | 1w |
|---|---|
| Celldex Therapeutics | -6.274% |
| iShares Core DAX® | -1.756% |
| iShares Nasdaq 100 | 2.324% |
| iShares Nikkei 225® | 5.022% |
| iShares S&P 500 | 0.802% |
Comments by Wells_Fargo___Compan for this prediction
In the thread Celldex Therapeutics diskutieren
Celldex Therapeutics (CLDX) had its price target raised by Wells Fargo & Company from $38.00 to $54.00. They now have an "overweight" rating on the stock.
Ratings data for CLDX provided by MarketBeat
Stopped prediction by Wells_Fargo___Compan for Celldex Therapeutics
Celldex Therapeutics
Start price
Target price
Perf. (%)
€18.40
20.08.25
20.08.25
€32.67
20.08.26
20.08.26
35.05%
03.06.26
03.06.26
